,title,source,link,date
1,Ambroxol and Acebrophylline Industry 2030 | Bidachem S.p.A. Hwail ...,Argyle Report,news.google.com/articles/CBMiowFodHRwczovL3d3dy5hcmd5bGVyZXBvcnQuY29tL25ld3MvYW1icm94b2wtYW5kLWFjZWJyb3BoeWxsaW5lLWluZHVzdHJ5LTIwMzAtYmlkYWNoZW0tcy1wLWEtaHdhaWwtcGhhcm0tY28tbHRkLXNoaWxwYS1tZWRpY2FyZS1saW1pdGVkLWNoYW5nemhvdS1zaXlhby1waGFybS8xMTYzMzkv0gEA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-01
33,APA Council Reports | American Journal of Psychiatry,Am J Psychiatry,news.google.com/articles/CBMiPmh0dHBzOi8vYWpwLnBzeWNoaWF0cnlvbmxpbmUub3JnL2RvaS8xMC4xMTc2L2FwcGkuYWpwLjIzMTgwMDEx0gEA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-01
0,"Vishnukanth Bhutada Shilpa Medicare Limited's (NSE:SHILPAMED) CEO is the most bullish insider, and their stock value gained 12%last week",Simply Wall St,news.google.com/articles/CBMingFodHRwczovL3NpbXBseXdhbGwuc3Qvc3RvY2tzL2luL3BoYXJtYWNldXRpY2Fscy1iaW90ZWNoL25zZS1zaGlscGFtZWQvc2hpbHBhLW1lZGljYXJlLXNoYXJlcy9uZXdzL3Zpc2hudWthbnRoLWJodXRhZGEtc2hpbHBhLW1lZGljYXJlLWxpbWl0ZWRzLW5zZXNoaWxwYW1lZC1jZdIBogFodHRwczovL3NpbXBseXdhbGwuc3Qvc3RvY2tzL2luL3BoYXJtYWNldXRpY2Fscy1iaW90ZWNoL25zZS1zaGlscGFtZWQvc2hpbHBhLW1lZGljYXJlLXNoYXJlcy9uZXdzL3Zpc2hudWthbnRoLWJodXRhZGEtc2hpbHBhLW1lZGljYXJlLWxpbWl0ZWRzLW5zZXNoaWxwYW1lZC1jZS9hbXA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-10-31
